AU21 Capital

AU21 Capital is a venture capital firm focused on investing in blockchain technology. Founded in 2017, AU21 Capital combines decades of executive and operational experience from industry leaders like Huobi and Galaxy Digital. The firm invests primarily in early-stage and seed investments, supporting companies that are pushing the boundaries of blockchain technology. AU21 Capital’s portfolio includes notable projects such as Axie Infinity, Injective, Marlin, Cere, Covalent, Casper Labs, Serum, Fantom, Harmony, Iotex, Coin98, Polkadot, and Star Atlas. The firm is known for its deep involvement in the development and growth of these companies, often collaborating with top exchanges and launchpads to bring innovative products to market. The leadership team at AU21 Capital leverages its extensive network and expertise to provide strategic guidance, business development, and market positioning for its portfolio companies. This hands-on approach ensures that the startups they back are well-equipped to navigate the challenges of the blockchain industry and achieve significant growth.